Policy for the treatment? The treatment will most certainly be offers to our beneficiaries as soon as the corneal specialists are trained on it. They have been waiting excitedly for FDA approval.
Policy for kerataconus as a DQ to entry? Wouldn't count on that changing anytime soon, if ever.